Sunshine Biopharma Inc. warrant
SBFMW
About: Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Employees: 52
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 3 [Q1] → 3 (+0) [Q2]
1.55% less ownership
Funds ownership: 3.02% [Q1] → 1.47% (-1.55%) [Q2]
10% less capital invested
Capital invested by funds: $12.2K [Q1] → $11K (-$1.2K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Financial journalist opinion
We haven’t received any recent news articles for SBFMW